Pathologies related to the cardiovascular system are the leading causes of death worldwide.
One of the main treatments is conventional surgery with autologous transplants. Although …

Cardiovascular disease is a primary cause of mortality worldwide, and patients often require
bypass surgery that utilizes autologous vessels as conduits. However, the limited availability …

Biofabrication approaches toward the development of tissue-engineered vascular grafts
(TEVGs) have been widely investigated. However, successful translation has been limited to …

Electrospinning is commonly used to generate polymeric scaffolds for tissue engineering.
Using this approach, we developed a small-diameter tissue engineered vascular graft …

Tissue engineering is a promising approach for the production of small‐diameter vascular
grafts; however, there are limited data directly comparing the suitability of applicable cell …

In this study, we contrast the impacts of surface coating bacterial nanocellulose small-
diameter vascular grafts (BNC-SDVGs) with human albumin, fibronectin, or heparin …

Small-caliber vascular grafts are used in a wide range of clinical conditions. However, there
remains a substantial unfulfilled need for readily-available, synthetic vascular grafts with …

Long‐term in vivo observation in large animal model is critical for evaluating the potential of
small diameter tissue engineering vascular graft (SDTEVG) in clinical application, but is …

The exploration of the next-generation small diameter vascular grafts (SDVGs) will never
stop until they possess high biocompatibility and patency comparable to autologous native …

Cardiovascular diseases have been the leading cause of global mortality and disability. In
addition to traditional drug and surgical treatment, more and more studies investigate tissue …